SoundHound AI (SOUN) had the highest return in February 2024 by a mid-cap US stock, returning 336.5%.
| ASSET | MONTH | % RETURN |
|---|---|---|
SoundHound AI (SOUN) | February 2024 | 336.47% |
Viking Therapeutics (VKTX) | February 2024 | 217.08% |
D-Wave Quantum (QBTS) | February 2024 | 107.87% |
CleanSpark (CLSK) | February 2024 | 106.42% |
Iovance Biotherapeutics (IOVA) | February 2024 | 102.68% |
Trevi Therapeutics (TRVI) | February 2024 | 100% |
Arcutis Biotherapeutics (ARQT) | February 2024 | 81.95% |
Acm Research (ACMR) | February 2024 | 76.89% |
Lifestance Health (LFST) | February 2024 | 75.79% |
AXT (AXTI) | February 2024 | 71.6% |
Celsius (CELH) | February 2024 | 63.24% |
Beam Therapeutics (BEAM) | February 2024 | 60.79% |
Cogent Biosciences (COGT) | February 2024 | 58.01% |
Intuitive Machines (LUNR) | February 2024 | 55.81% |
Nurix Therapeutics (NRIX) | February 2024 | 55.54% |
Sellas Life Sciences (SLS) | February 2024 | 54.69% |
Powell Industries (POWL) | February 2024 | 54.64% |
Galaxy Digital (GLXY) | February 2024 | 53.91% |
Hims Hers Health (HIMS) | February 2024 | 51.63% |
Dave (DAVE) | February 2024 | 49.06% |
Bandwidth (BAND) | February 2024 | 47.03% |
Kodiak Sciences (KOD) | February 2024 | 46.94% |
Rigetti Computing (RGTI) | February 2024 | 46.88% |
Definium Therapeutics (DFTX) | February 2024 | 46.54% |
Immunome (IMNM) | February 2024 | 43.2% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.